Skip to content

Gelfand LAB

Mission Statement:

To apply evolving knowledge of immunology, pharmacology, and light- based mechanisms to create novel therapeutic approaches for immune, cancer, and infectious diseases.

Research Focus:

Create devices and therapeutics to address longstanding clinical deficiencies and therapeutic needs

VIC Projects List

Highlighted Publications

Vitamin K3 (Menadione) is a Multifunctional Microbicide acting as a Photosensitizer and Synergizing with Blue Light to Kill Drug-Resistant Bacteria in Biofilms.

Journal of Photochemistry and Photobiology B: Biology. 2023 May;244:112720.
Negri LB, Mannaa Y, Korupolu S, Farinelli WA, Anderson RR, Gelfand JA.

Photoinactivation of Moraxella Catarrhalis Using 405-nm Blue Light: Implications for the Treatment of Otitis Media.

Photochem Photobiol. 2020 May; 96(3):611-617. PMID: 32105346.
Liu X, Chang Q, Ferrer-Espada R, Leanse LG, Goh XS, Wang X, Gelfand JA, Dai T

A Pilot Clinical Trial of a Near–Infrared Laser Vaccine Adjuvant: Safety, Tolerability, and Cutaneous Immune Cell Trafficking.

FASEB J. 2019 Feb;33(2):3074-3081. Doi: 10.1096/fj.201801095R. PMID: 30192655
Gelfand JA, Nazarian R, Kashiwagi S, Brauns T, Martin B, Kimizuka Y, Botvinick E , Elkins K,   Thomas L, Locascio J, Parry B, Kelly KM, Poznansky MC.

Antimicrobial Photodynamic Therapy Mediated By Methylene Blue And Potassium Iodide To Treat Urinary Tract Infection In A Female Rat Model.

Sci Rep. 2018 May 8;8(1):7257. doi: 10.1038/s41598-018-25365-0. PMID: 29740035 Huang YY, Wintner A, Seed PC, Brauns TA, Hamblin MR, Gelfand JA. 

Tetracyclines Function As Dual-Action Light-Activated Antibiotics.

PLoS One. 2018 May 9;13(5):e0196485. doi: 10.1371/journal.pone.0196485. PMID: 29742128
He Y, Huang YY, Liyan X, Gelfand JA*, Hamblin MR*. Tetracyclines function as dual-action light-activated antibiotics.

Antimicrobial Photodynamic Inactivation Mediated By Tetracyclines In Vitro And In Vivo: Photochemical Mechanisms And Potentiation By Potassium Iodide.

Sci Rep. 2018 Nov 20.;8:17130. doi: 10.1038/s41598-018-35594-y PMCID: PMC6244358 Weijun Xuan, Ya He, Liyi Huang, Ying-Ying Huang, Brijesh Bhayana, Liyan Xi, Jeffrey A. Gelfand, Michael R. Hamblin.

A Paradigm-Changing Approach for Combating Antibiotic-Resistant Gonococcal Infection.

J Infect Dis. 2019 July 31; 220(5):873-881. PMID: 30629196; PMCID: PMC6667797.
Wang Y, Ferrer-Espada R, Baglo Y, Goh XS, Held KDGrad YH, Gu Y, Gelfand JA, Dai T

Clinical sensitivity and Interpretation of PCR and Serological COVID-19 Diagnostics for Patients Presenting to the Hospital.

FASEB J. 2020 10; 34(10):13877-13884. PMID: 32856766; PMCID: PMC7461169.


Jeffrey A Gelfand, MD

Principal Investigator

Laisa Bonafim Negri, Ph.D.

Research Fellow

Timothy Brauns, MBA

Technology Development Advisor



2021 Yara Mannaa, BA, Boston University


Help us to advance now the medicines of the future.